It’s a new way to create “bi-paternal” mice that can survive to adulthood—but human applications are still a long way off.

Complementary discoveries have the potential to enhance treatment options for antibiotic-resistant infections. Researchers at ...

The epigenetic state of chromatin, gene activity, and chromosomal positions are interrelated. A research team from the IPK ...

A £1.65 million treatment has been approved for use for some NHS patients, offering some with an inherited blood disorder ...

Charity organisation Sickle Cell Society has described the recommendation as a “major breakthrough” for sickle cell patients.

Jim Cramer, the host of Mad Money, reflected on the uncertainty surrounding the year 2025, focusing on several macroeconomic ...

Researchers use CRISPR to overcome seemingly insurmontable reproductive barriers — but that doesn't mean this could work for ...

Leerink Partnrs boosted their FY2024 earnings per share (EPS) estimates for CRISPR Therapeutics in a note issued to investors ...

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modelling and interrogating human disease.

Experts hailed exciting news for some people with sickle cell disease in England as the health watchdog decided to grant ...

RFK Jr.'s comments about the gene-editing technology raise a question about how he would regulate it as head of HHS.

Despite continued underperformance in 2024, the biotech sector enters 2025 with a brighter outlook driven by groundbreaking ...